What is Khiron Life Sciences Corp. (KHRN.V)?

Khiron Life Sciences Corp. (KHRN.V) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

Khiron Life Sciences Corp. (KHRN.V)

Stock analysis · TSXV · Healthcare · Drug Manufacturers - Specialty & Generic

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

2.64

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Khiron Life Sciences Corp. (KHRN.V) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Nov 30, 2022

EPS $-0.02 vs est. $-0.02

Beat by $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About Khiron Life Sciences Corp.

Khiron Life Sciences Corp. is an integrated enterprise focusing on medical and cannabis solutions across Latin America and Europe. Its operations are structured into Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company's primary activities include the cultivation, production, distribution, and international export of medical cannabis, encompassing both tetrahydrocannabinol (THC) and cannabidiol (CBD). Complementing this, Khiron manages a network of health centers and satellite clinics, operating under the ILANS and Zerenia brands, with specific Zerenia clinics established in Medellin and Peru. Furthermore, it develops CBD-infused cosmeceutical products marketed under the Kuida brand. Khiron Life Sciences Corp. was founded in 2012 and maintains its headquarters in Vancouver, Canada.